Board of Directors 2025-2026
President (2025-2026)
Uwe Siebert, MD, MPH, ScD
Professor for Public Health, Medical Decision Making and Health Technology Assessment
UMIT TIROL - University for Health Sciences and Technology
Tirol, Austria
Past-President (2024-2025)
Eberechukwu Onukwugha, PhD
Professor, University of Maryland
Baltimore, Maryland, USA
President-Elect (2025-2026)
Beth Devine, PhD, PharmD, MBA
Professor Emeritus, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle, WA, USA
Director (2023-2026)
Dalia Dawoud, PhD
Professor at the Faculty of Pharmacy
Cairo University, Egypt
Biography and Vision Statement
Director (2024-2027)
Elisabeth Fenwick, PhD, MSc
Chief Science Officer
Open Health Group
London, England, UK
Director (2024-2027)
Ramiro Gilardino, MD, MSc
Healthcare Executive
Zurich, Switzerland
Director (2024-2027)
Daniel Ollendorf, PhD
Chief Scientific Officer and Director of HTA Methods and Engagement
Institute for Clinical and Economic Review
Boston, MA, USA
Director (2023-2026)
Lucinda Orsini, DPM, MPH
Vice President for Value and Outcomes Research, COMPASS Pathways
Skillman, New Jersey, USA
Biography and Vision Statement
Director (2023-2026)
Amy O’Sullivan, PhD
Senior Vice President and Chief Scientific Officer, Ontada
Boston, Massachusetts, USA
Biography and Vision Statement
Director (2024-2027)
Katja Rudell, PhD
Vice President, Patient Centred Outcomes
Kielo Research
Cambridge, United Kingdom
Treasurer (2020-2026)
Sean D. Sullivan, BScPharm, MSc, PhD,
Professor, University of Washington, School of Pharmacy
Seattle, Washington, USA
CEO & Executive Director
Rob Abbott
CEO & Executive Director
ISPOR-The Professional Society for Health Economics and Outcomes Research
Lawrenceville, New Jersey, USA